Individualizing therapy – in search of approaches to maximize the benefit of drug treatment (II)

AUTOR(ES)

Pater, Cornel

FONTE

BioMed Central

RESUMO

Adjusting drug therapy to the individual, a common approach in clinical practice, has evolved from 1) dose adjustments based on clinical effects to 2) dose adjustments made in response to drug levels and, more recently, to 3) dose adjustments based on deoxyribonucleic acid (DNA) sequencing of drug-metabolizing enzyme genes, suggesting a slow drug metabolism phenotype. This development dates back to the middle of the 20th century, when several different drugs were administered on the basis of individual plasma concentration measurements. Genetic control of drug metabolism was well established by the 1960s, and pharmakokinetic-based individualized therapy was in use by 1973.

Documentos Relacionados

• Breast Cancer Therapy Annual – today's drug treatment of cancer?
• Approaches to the Validation of Manipulation Therapy
• Complexos a - diiminicos de platina (II)
• Novel Changes in Resident Education during a Pandemic: Strategies and Approaches to Maximize Residency Education and Safety
• Different approaches to the treatment of skeletal Class II malocclusion during growth: Bionator versus extraoral appliance